To checkout the uncensored extended version of Prepped Life click below!* *Check out my … Watch full video on YouTube
William Miller on February 1, 2026 2:22 pm Nice to see insider buying—usually a good signal in this space. Reply
Emma C. Jackson on February 1, 2026 2:23 pm Nice to see insider buying—usually a good signal in this space. Reply
William Q. Rodriguez on February 1, 2026 2:25 pm I like the balance sheet here—less leverage than peers. Reply
Olivia Garcia on February 1, 2026 2:25 pm I like the balance sheet here—less leverage than peers. Reply
Amelia Williams on February 1, 2026 2:27 pm Exploration results look promising, but permitting will be the key risk. Reply
Jennifer Martinez on February 1, 2026 2:27 pm Exploration results look promising, but permitting will be the key risk. Reply
Linda Johnson on February 1, 2026 2:27 pm Interesting update on Sleeper Cells in the USA will attack after this…. Curious how the grades will trend next quarter. Reply
William R. Lopez on February 1, 2026 2:28 pm If AISC keeps dropping, this becomes investable for me. Reply
Ava Moore on February 1, 2026 2:30 pm Uranium names keep pushing higher—supply still tight into 2026. Reply
Noah Williams on February 1, 2026 2:32 pm Exploration results look promising, but permitting will be the key risk. Reply
Elijah White on February 1, 2026 2:33 pm Silver leverage is strong here; beta cuts both ways though. Reply
Mary Moore on February 1, 2026 2:34 pm Silver leverage is strong here; beta cuts both ways though. Reply
Michael D. Hernandez on February 1, 2026 2:34 pm Uranium names keep pushing higher—supply still tight into 2026. Reply
Noah Z. Taylor on February 1, 2026 2:35 pm Exploration results look promising, but permitting will be the key risk. Reply
Linda Jones on February 1, 2026 2:36 pm Interesting update on Sleeper Cells in the USA will attack after this…. Curious how the grades will trend next quarter. Reply
William X. Davis on February 1, 2026 2:36 pm The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
Michael R. Lopez on February 1, 2026 2:36 pm The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
39 Comments
Nice to see insider buying—usually a good signal in this space.
Nice to see insider buying—usually a good signal in this space.
Good point. Watching costs and grades closely.
I like the balance sheet here—less leverage than peers.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
I like the balance sheet here—less leverage than peers.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Exploration results look promising, but permitting will be the key risk.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Exploration results look promising, but permitting will be the key risk.
Interesting update on Sleeper Cells in the USA will attack after this…. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
If AISC keeps dropping, this becomes investable for me.
Good point. Watching costs and grades closely.
Uranium names keep pushing higher—supply still tight into 2026.
Exploration results look promising, but permitting will be the key risk.
Good point. Watching costs and grades closely.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
Uranium names keep pushing higher—supply still tight into 2026.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Exploration results look promising, but permitting will be the key risk.
Good point. Watching costs and grades closely.
Interesting update on Sleeper Cells in the USA will attack after this…. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.